Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Law

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistanceGrainne M O'Kane, Geoffrey Liu, Tracy L Stockley, et al.
Oncotarget|April 18, 2013
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Kristen M Reipas, Jennifer H Law, Nicole Couto, et al.
The Canadian Journal of Urology|August 11, 2021
The financial impact of cancer care on renal cancer patientsDoreen A Ezeife, Brendon Josh Morganstein, Steven Yip, et al.
Clinical Lung Cancer|February 25, 2019
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care SystemDoreen A Ezeife, Brandon Josh Morganstein, Sally Lau, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2018
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trialDarrel A Cook, Laurie W Smith, Jennifer H Law, et al.
JTO Clinical and Research Reports|June 20, 2022
Automating Access to Real-World EvidenceMarie-Pier Gauthier, Jennifer H Law, Lisa W Le, et al.
International Journal of Cancer|November 10, 2018
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trialDarrel A Cook, Mel Krajden, Adam R Brentnall, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center ExperienceShelley Kuang, Kaitlin Chen, Sachin Sayal, et al.
Cancer Research|March 25, 2010
Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistanceKaren To, Abbas Fotovati, Kristen M Reipas, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistanceGrainne M O'Kane, Geoffrey Liu, Tracy L Stockley, et al.
Oncotarget|April 18, 2013
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Kristen M Reipas, Jennifer H Law, Nicole Couto, et al.
The Canadian Journal of Urology|August 11, 2021
The financial impact of cancer care on renal cancer patientsDoreen A Ezeife, Brendon Josh Morganstein, Steven Yip, et al.
Clinical Lung Cancer|February 25, 2019
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care SystemDoreen A Ezeife, Brandon Josh Morganstein, Sally Lau, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2018
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trialDarrel A Cook, Laurie W Smith, Jennifer H Law, et al.
JTO Clinical and Research Reports|June 20, 2022
Automating Access to Real-World EvidenceMarie-Pier Gauthier, Jennifer H Law, Lisa W Le, et al.
International Journal of Cancer|November 10, 2018
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trialDarrel A Cook, Mel Krajden, Adam R Brentnall, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center ExperienceShelley Kuang, Kaitlin Chen, Sachin Sayal, et al.
Cancer Research|March 25, 2010
Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistanceKaren To, Abbas Fotovati, Kristen M Reipas, et al.
Pageof 3